LFCR Q1 2026 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q1 2026 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$31M+25.9% YoY

Gross Profit

$8M25.0% margin

Operating Income

-$3M-9.9% margin

Net Income

-$10M-32.1% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-14.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$25,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$235M

Total Liabilities

$198M

Stockholders' Equity

$37M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$25M	+25.9%
Gross Profit	$8M	$5M	+44.6%
Operating Income	-$3M	-$12M	+73.5%
Net Income	-$10M	-$16M	+38.4%